Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

EWTXEWTX
Showing 8 of 13 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in EDGEWISE THERAPEUTICS INC

Yes. Qube Research & Technologies holds 1,252,507 shares of EWTX (Edgewise Therapeutics), worth $50.9M, as of its Q2 2026 13F filing. It increased the position by 426,597 shares (+51.7%) from Q1 2026. Qube Research & Technologies has held EWTX since Q4 2023, across 11 quarterly 13F filings.

Current Value

$50.9M

Current Shares

1.3M

Total Value Change

+$47.4M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+51.6%
$50.9M0.0%$40.63
41
2026-Q1
Increased
825,910
+178.8%
$26M0.0%$28.81
46
2025-Q4
Decreased
296,208
-46.7%
$7.4M0.0%$24.54
0
2025-Q3
Increased
555,713
+11.2%
$9M0.0%$15.75
31
2025-Q2
Increased
499,917
+25.7%
$6.6M0.0%$13.17
34
2025-Q1
Increased
397,573
+7.6%
$8.7M0.0%$23.27
30
2024-Q4
Increased
369,442
+180.1%
$9.9M0.0%$27.06
45
2024-Q3
Increased
131,892
+357.2%
$3.5M0.0%$26.09
43

Other major holders of EWTX: RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., Jupiter Topco LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used